LOGICAL THERAPEUTICS, INC. IN-LICENSES NOVEL ANTI-INFLAMMATORY DRUG

Logical Therapeutics, Inc. (Pittsburgh, PA) has entered into a licensing and collaboration agreement with Medinox, Inc. (Carlsbad, CA) for a novel non-steroidal anti-inflammatory agent (NSAID), to be known as LT-NS001.
Yahoo Finance